Clinical Trial Update: 18F-fluoroestradiol (FES) PET/CT for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for 18F-fluoroestradiol PET/CT in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• [18F]Fluoroestradiol (fluoroestradiol (18F))

Snippet

Sponsor: Hoag Memorial Hospital Presbyterian | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN